A methodologic framework for developing and selecting endpoints in clinical trials.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002170:Canada; D002986:Clinical Trials as Topic; D006801:Humans; D012107:Research Design; D012216:Rheumatic Diseases / Q000188:drug therapy; D012219:Rheumatology / Q000379:methods*; D013223:Statistics as Topic; D014481:United States
D000893:Anti-Inflammatory Agents